A clinical trial to see the effect of an Ayurvedic preparation, Vasamruta Guggulu Ghrita in Individuals with Myopia (Pratham -Dwitiya Patalagata Timira)

A randomized controlled Trial to evaluate efficacy of oral administration of Vasamruta Guggulu Ghrita with spectacles in Pratham-Dwitiya Patalgata Timira with reference to Myopia. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106414

Enrollment

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient Enrolled with symptoms of Prathama-Dwitiya Patalagata Timira i.e. Avakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient nature of blurriness), Dooramnekshate (difficulty of distant vision) in Shalakya OPD. 2. Age-19 to 40 years. 3. Patient who have less than -3D refractive index in the eyes. 4. Patient of either gender. 5. Patient having visual acuity of 6/12, 6/18, 6/24, 6/36, 6/60, or less than 6/60 in the eyes. 6. Patient who is ready to give consent.

Exclusion criteria

Exclusion criteria: 1) Patient who have symptoms of Tritiya and Chaturtha Patalagata Timira will be excluded. 2) Congenital type of myopia, pathological type of myopia, acquired or secondary type of myopia that occurs due to some factors or diseases i.e. post traumatic, drug induced, post keratitis. etc. will be excluded. 3) Myopia associated with other ocular diseases like cataract, glaucoma, etc. 4) Patient who have myopia associated with other refractive errors such as astigmatism, presbyopia. 5) Patient who have known case of hypertension, diabetes mellitus, Rheumatic arthritis or any other arthritic conditions, rheumatic heart disease, thyroid disorder, asthma, Koch s, HIV will be excluded. 6) Patient who have active infectious diseases i.e. viral, fungal, bacterial conjunctivitis , trachoma, blepharitis. 7) Patient below 16 years and above 40 years will be excluded. 8) Patient who have refractive index more than -3D will be excluded.

Design outcomes

Primary

Measure	Time frame
Symptoms like avyakatmekshateroopam (visual hallucination), Vyaktamapyanimitta (transient nature of blurriness), Dooramnekshate will be decreasedTimepoint: Follow up on 15th and 30th Day.Symptoms will be noted before and after treatment. Observational follow up will be on 45th Day	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactProf Dr Sumedha Y Kotangale

MAMS Sumatibhai Shah Ayurved Mahavidyalaya

sumedhayk@yahoo.com8275298480

Outcome results